Search research articles
Contact Us
Filters
Showing results (151-160 of 260) with videos related to
Page
of 26
Sort By:
Cancer Treatment Reports
|
April 1, 1985
Modulation of the activity of PALA by dipyridamole
T C Chan, B Young, M E King, et al.
The European Journal of Surgery. Supplement. : = Acta Chirurgica. Supplement
|
May 1, 1991
Cellular pharmacologic strategies for overcoming drug resistance: potential applications to regional therapy
S B Howell, S Isonishi, R D Christen, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1995
Synergistic interaction between cisplatin and tamoxifen delays the emergence of cisplatin resistance in head and neck cancer cell lines
B Nakata, K D Albright, R M Barton, et al.
The American Journal of Medicine
|
January 1, 1985
Infectious peritonitis in patients receiving intraperitoneal chemotherapy
R A Kaplan, M Markman, W E Lucas, et al.
Cancer Research
|
June 15, 1989
Comparison of the synergistic potentiation of etoposide, doxorubicin, and vinblastine cytotoxicity by dipyridamole
S B Howell, D Hom, R Sanga, et al.
Cancer Research
|
October 19, 2001
Hypoxia-induced enrichment and mutagenesis of cells that have lost DNA mismatch repair
A Kondo, R Safaei, M Mishima, et al.
Cancer Research
|
January 1, 1988
Pharmacokinetics of intraperitoneally administered dipyridamole in cancer patients
T C Chan, G L Coppoc, S Zimm, et al.
Cancer
|
September 15, 1981
Modulation of 5-fluorouracil toxicity by allopurinol in man
S B Howell, W E Wung, R Taetle, et al.
International Journal of Cancer
|
March 17, 2001
Quantification of tumor cell injury in vitro and in vivo using expression of green fluorescent protein under the control of the GADD153 promoter
X Lin, D P Gately, D Hom, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1984
Combination intraperitoneal chemotherapy with cisplatin, cytarabine, and doxorubicin for refractory ovarian carcinoma and other malignancies principally confined to the peritoneal cavity
M Markman, S B Howell, W E Lucas, et al.
Page
of 26
Search research articles
Search
Showing results (151-160 of 260) with videos related to
Sort By:
Page
of 26
Cancer Treatment Reports
|
April 1, 1985
Modulation of the activity of PALA by dipyridamole
T C Chan, B Young, M E King, et al.
The European Journal of Surgery. Supplement. : = Acta Chirurgica. Supplement
|
May 1, 1991
Cellular pharmacologic strategies for overcoming drug resistance: potential applications to regional therapy
S B Howell, S Isonishi, R D Christen, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1995
Synergistic interaction between cisplatin and tamoxifen delays the emergence of cisplatin resistance in head and neck cancer cell lines
B Nakata, K D Albright, R M Barton, et al.
The American Journal of Medicine
|
January 1, 1985
Infectious peritonitis in patients receiving intraperitoneal chemotherapy
R A Kaplan, M Markman, W E Lucas, et al.
Cancer Research
|
June 15, 1989
Comparison of the synergistic potentiation of etoposide, doxorubicin, and vinblastine cytotoxicity by dipyridamole
S B Howell, D Hom, R Sanga, et al.
Cancer Research
|
October 19, 2001
Hypoxia-induced enrichment and mutagenesis of cells that have lost DNA mismatch repair
A Kondo, R Safaei, M Mishima, et al.
Cancer Research
|
January 1, 1988
Pharmacokinetics of intraperitoneally administered dipyridamole in cancer patients
T C Chan, G L Coppoc, S Zimm, et al.
Cancer
|
September 15, 1981
Modulation of 5-fluorouracil toxicity by allopurinol in man
S B Howell, W E Wung, R Taetle, et al.
International Journal of Cancer
|
March 17, 2001
Quantification of tumor cell injury in vitro and in vivo using expression of green fluorescent protein under the control of the GADD153 promoter
X Lin, D P Gately, D Hom, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1984
Combination intraperitoneal chemotherapy with cisplatin, cytarabine, and doxorubicin for refractory ovarian carcinoma and other malignancies principally confined to the peritoneal cavity
M Markman, S B Howell, W E Lucas, et al.
Page
of 26